Read more about Moderna lowers forecast for 2021 Covid-19 vaccine deliveries on Business Standard. Moderna makes one of three Covid-19 vaccines currently being used in the United States
Moderna is scaling back expectations for the number of COVID-19 vaccine deliveries it expects to make this year and the revenue it will record from them. The drugmaker said Thursday that longer delivery lead times for exports and a temporary impact from expanding its fill-finish capacity may shift some deliveries to early 2022.
